secwatch.observer — SEC 8-K summary
======================================

Issuer:     ADMA BIOLOGICS, INC. (ADMA)
CIK:        0001368514
Form:       8-K
Filed at:   2024-06-28T23:59:59+00:00
Accession:  0001140361-24-031778
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ADMA Biologics amends bylaws to reduce director removal threshold to majority vote and add exclusive forum provisions
--------------------------------------------------------------------------------

- Reduced director removal with cause threshold from 66 2/3% to a majority of voting holders.
- Added exclusive forum provision requiring internal corporate suits be brought in Delaware courts.
- Added federal forum selection clause for Securities Act claims unless company consents otherwise.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1368514/000114036124031778/0001140361-24-031778-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1368514/000114036124031778/ef20031848_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-031778

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer